Anitocabtagene Autoleucel Clinical Trials
2 recruitingDrug
Phase 21Phase 31
Showing 1–2 of 2 trials
Recruiting
Phase 3
A Study Comparing Anitocabtagene Autoleucel to Standard of Care Therapy in Participants With Relapsed/ Refractory Multiple Myeloma
Multiple Myeloma
Kite, A Gilead Company450 enrolled124 locationsNCT06413498
Recruiting
Phase 2
Efficacy and Safety of Anitocabtagene Autoleucel in Participants With Newly Diagnosed Multiple Myeloma (GEM-AnitoFIRST)
De Novo Multiple MyelomaAnitocabtagene Autoleucel
PETHEMA Foundation30 enrolled10 locationsNCT07045909